Assessment On Prevalence Modifiable Risk Factors, Treatment Trends By Using National Stroke Scale and SSS In Stroke Patients

Author(s)

HimaBindu, G., SureswaraReddy, M., Sai Sumanth Reddy, A., Bhargavi, C.

Author's Affiliation

Abstract

To estimate prevalence and treatment trends in stroke individuals and to assess the severity of risk factors in stroke and stroke severity using national stroke scale and Scandinavian stroke scale. We conducted a prospective observational study in a Rajiv Gandhi institute of medical sciences in kadapa from November 2016 to April 2017. A total of 192 subjects of both sexes was included in the data analysis. According to national stroke scale it is used to assess the severity of risk factors in the stroke individuals and Scandinavian stroke scale it is used to assess the stroke severity in patients diagnosed as stroke. It was observed that the prevalence of ischemic stroke (79.1 %) was higher when compared to hemorrhagic stroke (20.9 %). The incidence of stroke was estimated higher in males (59.37 %) as compared to females (40.63 %). Hypertension (91.9 %) was the profound causative risk factor for stroke followed by hyperlipidemia (67.7 %), alcohol (36.9 %), diabetes mellitus (35.4 %), smoking (30.2 %) (X² = 73.75, p value < 0.0001). The common prescribing trends for stroke patients were cognitive enhancer nootrophil (71.3 %). Followed by dyslipidemics (67.1%), anti-platelets (61.4%), anti-hypertensive’s (38.5%), and anticoagulants (3.6%). Our study findings concluded knowledge of the risk factors for stroke in stroke survivors was very low and based on their level of education; we counselled the study subjects and recommended the medication adherence.

Keywords

Stroke, Prevalence, Risk Factors, Scandinavian Stroke Scale (SSS), National Stroke Scale (NSS) Treatment Trends

Cite This Article

HimaBindu, G., SureswaraReddy, M., Sai Sumanth Reddy, A., Bhargavi, C. (2017). Assessment On Prevalence Modifiable Risk Factors, Treatment Trends By Using National Stroke Scale and SSS In Stroke Patients, International Journal for Pharmaceutical Research Scholars (IJPRS), 6(4), 12-19.